VIMIAN GROUP AB revenue for the last year amounted to 3.71 B SEK, the most of which — 1.69 B SEK — came from its highest performing source at the moment, Specialty Pharma, the year earlier bringing 1.32 B SEK. The greatest contribution to the revenue figure was made by United States — last year it brought VIMIAN GROUP AB 1.43 B SEK, and the year before that — 1.21 B SEK.